SIM
BPMC

Sonora Investment Management’s Blueprint Medicines BPMC Stock Holding History

Sonora Investment Management’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-95
Closed -$9K – 995
2021
Q1 		$9K Hold
95
– – ﹤0.01% 1337
2020
Q4 		$11K Buy
+95
New +$10K ﹤0.01% 1160
2020
Q3 		– Sell
-26
Closed -$2K – 1779
2020
Q2 		$2K Buy
+26
New +$1.76K ﹤0.01% 1563

Other funds holding BPMC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Sonora Investment Management's BPMC Position: Q2 2021 in Review

Sonora Investment Management sold out of Blueprint Medicines (BPMC) in Q2 2021, closing a stake of 95 shares — an estimated $9K sold.

Sonora Investment Management first reported a position in BPMC in Q2 2020 and held it in 3 quarters. The position peaked at $11K in Q4 2020. 281 funds tracked by Wall St. Rank hold BPMC as of Q2 2021.

  • Sonora Investment Management reported no remaining Blueprint Medicines position as of Q2 2021 after selling out during the quarter.
  • Sonora Investment Management sold 95 Blueprint Medicines shares in Q2 2021, an estimated $9K.
  • Sonora Investment Management first reported a position in Blueprint Medicines in Q2 2020 and held it in 3 quarters.
  • Sonora Investment Management's Blueprint Medicines position peaked at $11K in Q4 2020.
  • 281 funds tracked by Wall St. Rank held Blueprint Medicines as of Q2 2021.

Based on Sonora Investment Management's 13F filing for Q2 2021, filed 20 Oct 2021.